Events and conventions
Hall Federico Vecchio, Policlinic of Bari, Presentation of the Patient’s Guide ‘Living well with Thalassemia’. The guide is made by the Gianni Benzi Pharmacological Research Foundation in collaboration with the Italian Foundation ‘Leonardo Giambrone’ for the Healing of Thalassemia, within the international DEEP project.
‘Research, Innovation and Competitiveness: which advantages for the country and the patients?’. Cycle of meetings organised in collaboration with the Cultural Association ‘Giuseppe Dossetti: I Valori’. The cycle included the following initiatives:
‘Medicines: a leading sector for Research and Development? From Industry 2015 to Horizon 2020′;
‘Medicines: which destiny after the authorisation’;
‘The clinical trial, progression Authorisation and special uses: an opportunity for Italy and for Europe?’
Hall Zuccari, Senato, Palazzo Giustiniano, ‘L’Odontostomatologia: un importante supporto per la qualità della vita nel paziente oncologico.’ The conference was organised in collaboration with the Osservatorio Sanità e Salute.
Fiera del Levante ‘Brevetti, Biotecnologie e Innovazione nella realtà regionale Pugliese’ for the promotion of intellectual property rights in the life-science field. The Conference was organised in collaboration with CNRB and ARTI, the Regional Agency for Technology and Innovation.
Salone degli Affreschi, Palazzo Ateneo, First Scientific Day, organised in collaboration with the Pharmaco-biological Department, University of Bari. The conference was aimed to provide an analysis of the activities promoted by the Gianni Benzi Foundation in its first two years of activity, realised through projects, awards and national and international scientific partnerships. On that occasion, the prize “To continue the fight against Doping” was awarded.
Symposium entitled ‘La CIPN – Neuropatia periferica indotta da chemioterapici: un problema clinico e farmacologico’ held on the occasion of the 34th Congress of the Italian Society of Pharmacology (SIF). The Symposium aim was to contribute to a better understanding of the disease and stimulate a broad discussion about the causes, the appropriate diagnostic pathways, the reference standards, the risk/benefit of neurotoxic treatment and the recent therapeutic perspectives.